Iwona Handzlik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iwona Handzlik has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Maria Myszkowska
Dr. Jan Biziel University Hospital No. 2, Bydgoszcz
8 shared publications - Patrycja Zawada-Wiśniewska
Dr. Jan Biziel University Hospital No. 2, Bydgoszcz
7 shared publications - Mateusz Krakowiak
Faculty of Medical Sciences and Health Sciences, Radom University, 29 Malczewskiego Street, 26-600 Radom, Poland
5 shared publications - Adam Ostrowski
Department of Urology and Andrology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, M. Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland
2 shared publications - Heimann N.
District Hospital named after Prof. Roman Drews, Chodzież
2 shared publications - Magdalena Ostrowska
Department of Otolaryngology and Laryngological Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, M. Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland
2 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1489-1496
Understanding Friendship Betrayal Delusions: A 2025 Psychiatric Analysis of Modern Lifestyle Diseases
Friendship betrayal delusions represent a growing psychiatric phenomenon within the spectrum of 21st century civilization diseases. Characterized by fixed false beliefs about the malicious intentions of trusted individuals, these delusions are influenced by neurobiological vulnerabilities, particularly dopaminergic dysregulation in mesolimbic pathways, and psychosocial factors such as social isolation, early attachment disruptions, and digital hyperconnectivity. They frequently co-occur with depression, anxiety, metabolic syndrome, and sleep disturbances, complicating diagnosis and treatment. Differentiation from borderline personality disorder, PTSD, and other psychiatric conditions requires structured clinical interviews and detailed assessment. Current treatment approaches integrate second-generation antipsychotics, such as risperidone and aripiprazole, with specialized cognitive-behavioral therapy for psychosis. Despite challenges in long-term management, these interventions show promising outcomes, emphasizing the importance of a comprehensive biopsychosocial understanding of friendship betrayal delusions as modern lifestyle-related psychiatric disorders.
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1489-1496
Open AccessUnderstanding Friendship Betrayal Delusions: A 2025 Psychiatric Analysis of Modern Lifestyle Diseases
Friendship betrayal delusions represent a growing psychiatric phenomenon within the spectrum of 21st century civilization diseases. Characterized by fixed false beliefs about the malicious intentions of trusted individuals, these delusions are influenced by neurobiological vulnerabilities, particularly dopaminergic dysregulation in mesolimbic pathways, and psychosocial factors such as social isolation, early attachment disruptions, and digital hyperconnectivity. They frequently co-occur with depression, anxiety, metabolic syndrome, and sleep disturbances, complicating diagnosis and treatment. Differentiation from borderline personality disorder, PTSD, and other psychiatric conditions requires structured clinical interviews and detailed assessment. Current treatment approaches integrate second-generation antipsychotics, such as risperidone and aripiprazole, with specialized cognitive-behavioral therapy for psychosis. Despite challenges in long-term management, these interventions show promising outcomes, emphasizing the importance of a comprehensive biopsychosocial understanding of friendship betrayal delusions as modern lifestyle-related psychiatric disorders.
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1482-1488
What Causes Schizophrenia? New Genetic Evidence Challenges Previous Theories
Studies of genetic linkage and twins show that hereditary factors strongly influence schizophrenia, with heritability estimates between 70% and 90%. This devastating psychiatric disorder affects about 1% of people worldwide. Its symptoms include hallucinations, emotional withdrawal, and cognitive decline. The genetic component plays a crucial role, but scientists still struggle to understand the precise genetic architecture behind it. Scientists have found that schizophrenia's genetic makeup is incredibly complex and polygenic. The research team's original hope was to identify a few genes with major effects that would explain the disorder's cause. Genome-wide association studies (GWAS) revealed a different story. The biggest GWAS published so far, which looked at 76,755 people with schizophrenia and 243,649 controls, found 287 significant genetic associations. These genetic variants usually have small effects, with odds ratios from 1.04 to 1.23. Together they explain just 2-3% of the disorder's variance. We have a long way to go, but we can build on this progress in identifying genetic risk factors. Evidence has emerged that links specific gene variants to biological processes like synaptic pruning—when connections between neurons are eliminated. This breakthrough provides the first causal link between schizophrenia and specific gene variants tied to a biological process. The standardized mortality ratio for schizophrenia patients is 2.6 compared to the general population. These numbers highlight why we need to better understand the mechanisms of this condition. This piece gets into how genetic discoveries challenge the original theories about schizophrenia's origins and what these findings mean for future research and treatment approaches.
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1482-1488
Open AccessWhat Causes Schizophrenia? New Genetic Evidence Challenges Previous Theories
Studies of genetic linkage and twins show that hereditary factors strongly influence schizophrenia, with heritability estimates between 70% and 90%. This devastating psychiatric disorder affects about 1% of people worldwide. Its symptoms include hallucinations, emotional withdrawal, and cognitive decline. The genetic component plays a crucial role, but scientists still struggle to understand the precise genetic architecture behind it. Scientists have found that schizophrenia's genetic makeup is incredibly complex and polygenic. The research team's original hope was to identify a few genes with major effects that would explain the disorder's cause. Genome-wide association studies (GWAS) revealed a different story. The biggest GWAS published so far, which looked at 76,755 people with schizophrenia and 243,649 controls, found 287 significant genetic associations. These genetic variants usually have small effects, with odds ratios from 1.04 to 1.23. Together they explain just 2-3% of the disorder's variance. We have a long way to go, but we can build on this progress in identifying genetic risk factors. Evidence has emerged that links specific gene variants to biological processes like synaptic pruning—when connections between neurons are eliminated. This breakthrough provides the first causal link between schizophrenia and specific gene variants tied to a biological process. The standardized mortality ratio for schizophrenia patients is 2.6 compared to the general population. These numbers highlight why we need to better understand the mechanisms of this condition. This piece gets into how genetic discoveries challenge the original theories about schizophrenia's origins and what these findings mean for future research and treatment approaches.
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1469-1475
Surgical Vs Traditional Schizophrenia Treatment: What Research Shows
Patients and clinicians face tough choices when standard schizophrenia treatments don’t bring relief. Pharmaceutical treatments have advanced over decades, but 30% of people with schizophrenia still experience symptoms that don’t respond well to conventional approaches. Treatment resistance remains the biggest problem in psychiatric care today. Surgical interventions have emerged as alternatives to think over for patients who’ve tried all first-line treatments. Antipsychotic medications are still the foundations of schizophrenia treatment protocols. The latest research suggests that targeted surgical procedures might offer hope for specific patient groups. These interventions—including Deep Brain Stimulation (DBS), Transcranial Magnetic Stimulation (TMS), and experimental approaches—mark a major shift from traditional management strategies. Schizophrenia treatment’s history shows a steady development from institutional confinement to community-based care. Psychosocial supports now work alongside pharmacological approaches. We have a long way to go, but we can build on this progress. Patients with treatment-resistant forms of the disorder often experience lower quality of life and major functional impairment, even when they follow first-line treatment recommendations. This piece gets into the evidence that compares surgical and traditional approaches for managing schizophrenia symptoms and treatment outcomes. We want to provide a complete overview of current treatment options and how well they work by analyzing clinical trial data, neuroimaging findings, and patient-reported experiences. It also explores the factors that should guide shared decision-making between patients and their healthcare providers as they evaluate these interventions.
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1469-1475
Open AccessSurgical Vs Traditional Schizophrenia Treatment: What Research Shows
Patients and clinicians face tough choices when standard schizophrenia treatments don’t bring relief. Pharmaceutical treatments have advanced over decades, but 30% of people with schizophrenia still experience symptoms that don’t respond well to conventional approaches. Treatment resistance remains the biggest problem in psychiatric care today. Surgical interventions have emerged as alternatives to think over for patients who’ve tried all first-line treatments. Antipsychotic medications are still the foundations of schizophrenia treatment protocols. The latest research suggests that targeted surgical procedures might offer hope for specific patient groups. These interventions—including Deep Brain Stimulation (DBS), Transcranial Magnetic Stimulation (TMS), and experimental approaches—mark a major shift from traditional management strategies. Schizophrenia treatment’s history shows a steady development from institutional confinement to community-based care. Psychosocial supports now work alongside pharmacological approaches. We have a long way to go, but we can build on this progress. Patients with treatment-resistant forms of the disorder often experience lower quality of life and major functional impairment, even when they follow first-line treatment recommendations. This piece gets into the evidence that compares surgical and traditional approaches for managing schizophrenia symptoms and treatment outcomes. We want to provide a complete overview of current treatment options and how well they work by analyzing clinical trial data, neuroimaging findings, and patient-reported experiences. It also explores the factors that should guide shared decision-making between patients and their healthcare providers as they evaluate these interventions.
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1476-1481
Microaneurysm Rupture Risk: Surprising Size-Based Findings in Brain Blood Vessels
The medical community has long linked microaneurysm rupture risk to size. Larger bulges were thought to be more dangerous. But recent clinical findings have turned this conventional wisdom on its head. Even the smallest aneurysms can seriously threaten brain health. Studies now show that tiny aneurysms (≤3 mm) cause much of the subarachnoid hemorrhage cases. This discovery challenges risk assessment protocols that doctors have used for decades. These small vascular abnormalities can show no warning signs before a catastrophic rupture. Scientists understand a lot about macroaneurysm rupture. The mechanisms behind small aneurysm failures remain nowhere near as clear. The anterior communicating artery (AComA) seems to increase rupture risk whatever the size. Research continues on whether fusiform aneurysms follow this same pattern. Medical teams still debate the best way to manage these dangerous vascular anomalies. This piece dives into fresh evidence that challenges size-based risk models for brain aneurysms. We'll learn about the surprising relationship between aneurysm size and rupture risk. The text explores location-specific vulnerability patterns and reviews current treatment approaches for these overlooked vascular threats. Doctors need this knowledge to make intervention decisions. Patients need it to weigh treatment options against the risk of catastrophic bleeding.
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1476-1481
Open AccessMicroaneurysm Rupture Risk: Surprising Size-Based Findings in Brain Blood Vessels
The medical community has long linked microaneurysm rupture risk to size. Larger bulges were thought to be more dangerous. But recent clinical findings have turned this conventional wisdom on its head. Even the smallest aneurysms can seriously threaten brain health. Studies now show that tiny aneurysms (≤3 mm) cause much of the subarachnoid hemorrhage cases. This discovery challenges risk assessment protocols that doctors have used for decades. These small vascular abnormalities can show no warning signs before a catastrophic rupture. Scientists understand a lot about macroaneurysm rupture. The mechanisms behind small aneurysm failures remain nowhere near as clear. The anterior communicating artery (AComA) seems to increase rupture risk whatever the size. Research continues on whether fusiform aneurysms follow this same pattern. Medical teams still debate the best way to manage these dangerous vascular anomalies. This piece dives into fresh evidence that challenges size-based risk models for brain aneurysms. We'll learn about the surprising relationship between aneurysm size and rupture risk. The text explores location-specific vulnerability patterns and reviews current treatment approaches for these overlooked vascular threats. Doctors need this knowledge to make intervention decisions. Patients need it to weigh treatment options against the risk of catastrophic bleeding.
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1409-1417
Biblical Medicine Practices: Ancient Health Guidelines and Their Medical Significance
This study examines the medical practices documented in biblical texts, focusing on their historical significance and potential modern applications. Through systematic analysis of ancient Hebrew and Greek manuscripts, along with archaeological evidence, we investigated the therapeutic approaches described in both Old and New Testaments. The research methodology combined textual analysis of original sources with comparative studies of contemporary Middle Eastern medical practices from 2000 BCE to 100 CE. Our findings reveal that biblical medical treatments often integrated physical remedies with spiritual practices, including the use of plant-based medicines, dietary laws, and quarantine procedures that demonstrated remarkable alignment with basic principles of modern hygiene and public health. This research contributes to our understanding of ancient medical knowledge and suggests that some biblical medical practices were grounded in empirical observations that maintain relevance in contemporary healthcare discussions. These findings provide valuable insights into the historical development of medical practices and the intersection of spiritual and physical healing in ancient Near Eastern cultures.
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1409-1417
Open AccessBiblical Medicine Practices: Ancient Health Guidelines and Their Medical Significance
This study examines the medical practices documented in biblical texts, focusing on their historical significance and potential modern applications. Through systematic analysis of ancient Hebrew and Greek manuscripts, along with archaeological evidence, we investigated the therapeutic approaches described in both Old and New Testaments. The research methodology combined textual analysis of original sources with comparative studies of contemporary Middle Eastern medical practices from 2000 BCE to 100 CE. Our findings reveal that biblical medical treatments often integrated physical remedies with spiritual practices, including the use of plant-based medicines, dietary laws, and quarantine procedures that demonstrated remarkable alignment with basic principles of modern hygiene and public health. This research contributes to our understanding of ancient medical knowledge and suggests that some biblical medical practices were grounded in empirical observations that maintain relevance in contemporary healthcare discussions. These findings provide valuable insights into the historical development of medical practices and the intersection of spiritual and physical healing in ancient Near Eastern cultures.
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1397-1408
Neurovascular Compression: New Evidence Reveals Better Pain Management Protocols
Neurovascular compression constitutes a significant etiopathogenic mechanism in various cranial nerve hyperactivity disorders, affecting approximately 5% of patients with unexplained cranial neuropathies. This study examines emerging evidence regarding the management of neurovascular compression syndromes, with particular focus on developments from the past five years. We conducted a comprehensive analysis of recent clinical trials and meta-analyses evaluating both pharmacological and surgical interventions. The pathophysiology involves mechanical distortion of cranial nerves by adjacent vascular structures at the root entry zone, leading to demyelination and ephaptic transmission. High-resolution neuroimaging has substantially altered our understanding of these conditions by enabling precise visualization of previously undetectable vascular conflicts. Our findings indicate that symptoms exist on a severity spectrum, with some patients responding well to pharmacological management alone, challenging the traditional paradigm favoring early surgical intervention. We propose a stratified management algorithm based on symptom severity, imaging findings, and patient characteristics that optimizes outcomes while minimizing unnecessary surgical procedures. Multiple vessel compression, purely venous compression, and previous destructive procedures were associated with less favorable surgical outcomes. This evidence-based approach establishes more standardized pain management protocols for these challenging neurological disorders, while identifying artificial intelligence applications and multimodal pain management as promising future directions
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1397-1408
Open AccessNeurovascular Compression: New Evidence Reveals Better Pain Management Protocols
Neurovascular compression constitutes a significant etiopathogenic mechanism in various cranial nerve hyperactivity disorders, affecting approximately 5% of patients with unexplained cranial neuropathies. This study examines emerging evidence regarding the management of neurovascular compression syndromes, with particular focus on developments from the past five years. We conducted a comprehensive analysis of recent clinical trials and meta-analyses evaluating both pharmacological and surgical interventions. The pathophysiology involves mechanical distortion of cranial nerves by adjacent vascular structures at the root entry zone, leading to demyelination and ephaptic transmission. High-resolution neuroimaging has substantially altered our understanding of these conditions by enabling precise visualization of previously undetectable vascular conflicts. Our findings indicate that symptoms exist on a severity spectrum, with some patients responding well to pharmacological management alone, challenging the traditional paradigm favoring early surgical intervention. We propose a stratified management algorithm based on symptom severity, imaging findings, and patient characteristics that optimizes outcomes while minimizing unnecessary surgical procedures. Multiple vessel compression, purely venous compression, and previous destructive procedures were associated with less favorable surgical outcomes. This evidence-based approach establishes more standardized pain management protocols for these challenging neurological disorders, while identifying artificial intelligence applications and multimodal pain management as promising future directions
- Open Access
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1443-1454
Palliative Care Dilemma: When Ventilation Support Conflicts with MS Patient Wishes
This paper examines the complex ethical, clinical, and legal considerations surrounding ventilation support decisions in patients with advanced multiple sclerosis (MS) when these interventions conflict with patient wishes. Respiratory complications represent a significant cause of morbidity and mortality in advanced MS, with patients having an 11.7-fold higher probability of respiratory-related death compared to the general population. [1,2] The decision-making process is complicated by cognitive and behavioral changes affecting 35-50% of patients with neurodegenerative diseases, potentially impairing their capacity for informed medical choices. [3,4] We explore the clinical course of respiratory decline in MS, objective criteria for initiating ventilation support, the importance of advance care planning, and the ethical tension between beneficence and patient autonomy. [5,6] The integration of palliative care approaches and structured decision-making frameworks offer practical strategies for navigating these challenges. [7,8] Our findings emphasize the importance of multidisciplinary collaboration, early advance care planning, and shared decision-making models that respect both medical indications and patient autonomy in these complex clinical scenarios. [9,10].
- 1 September 2025
- Published by Valley International in Clinical Medicine And Health Research Journal
- Vol. 5 (05) , 1443-1454
Open AccessPalliative Care Dilemma: When Ventilation Support Conflicts with MS Patient Wishes
This paper examines the complex ethical, clinical, and legal considerations surrounding ventilation support decisions in patients with advanced multiple sclerosis (MS) when these interventions conflict with patient wishes. Respiratory complications represent a significant cause of morbidity and mortality in advanced MS, with patients having an 11.7-fold higher probability of respiratory-related death compared to the general population. [1,2] The decision-making process is complicated by cognitive and behavioral changes affecting 35-50% of patients with neurodegenerative diseases, potentially impairing their capacity for informed medical choices. [3,4] We explore the clinical course of respiratory decline in MS, objective criteria for initiating ventilation support, the importance of advance care planning, and the ethical tension between beneficence and patient autonomy. [5,6] The integration of palliative care approaches and structured decision-making frameworks offer practical strategies for navigating these challenges. [7,8] Our findings emphasize the importance of multidisciplinary collaboration, early advance care planning, and shared decision-making models that respect both medical indications and patient autonomy in these complex clinical scenarios. [9,10].
- Open Access
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 60100
Pregnant Woman with Obesity: How to Diagnose and Treat Obesity During Pregnancy? A Review of Current Guidelines and Scientific Data
The aim of this article is to analyze the issue of obesity during pregnancy as a significant health challenge for both the mother and the developing fetus. Maternal obesity is associated with numerous health complications, including gestational diabetes and an increased risk of delivery interventions. The paper emphasizes the importance of proper diagnostics, nutritional education, and treatment in the care process for obese pregnant women. Current guidelines regarding weight gain during pregnancy and the role of an interdisciplinary team in minimizing the risk of complications are also discussed. An analysis of available studies and literature allows for a multifaceted approach to this issue.
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 60100
Open AccessPregnant Woman with Obesity: How to Diagnose and Treat Obesity During Pregnancy? A Review of Current Guidelines and Scientific Data
The aim of this article is to analyze the issue of obesity during pregnancy as a significant health challenge for both the mother and the developing fetus. Maternal obesity is associated with numerous health complications, including gestational diabetes and an increased risk of delivery interventions. The paper emphasizes the importance of proper diagnostics, nutritional education, and treatment in the care process for obese pregnant women. Current guidelines regarding weight gain during pregnancy and the role of an interdisciplinary team in minimizing the risk of complications are also discussed. An analysis of available studies and literature allows for a multifaceted approach to this issue.
- Open Access
- 12 October 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (11) , 192-197
Review of commercially available biomarkers in the diagnosis of prostate cancer
Introduction Diagnosing prostate cancer is a complex process. Although PSA testing remains the basic laboratory study, new biomarkers and test are evolving quickly. Aim The aim of this review was to summarize available tests and markers for diagnosing prostate cancer. Materials and methods Literature search was conducted using PubMed and Cohrane databases. Results and conclusions Detailed description of ExoDx, PCA3, SelectMDx, Mi-prostate Score, SChLAP1, PSA, PHI, 4K Score tests was presented. Available test ease qualification for a prostate biopsy or observation. Patients should be qualified individually in deciding on a specific test to be performed. Urologists should be aware of each test mechanism and limitations.
- 12 October 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (11) , 192-197
Open AccessReview of commercially available biomarkers in the diagnosis of prostate cancer
Introduction Diagnosing prostate cancer is a complex process. Although PSA testing remains the basic laboratory study, new biomarkers and test are evolving quickly. Aim The aim of this review was to summarize available tests and markers for diagnosing prostate cancer. Materials and methods Literature search was conducted using PubMed and Cohrane databases. Results and conclusions Detailed description of ExoDx, PCA3, SelectMDx, Mi-prostate Score, SChLAP1, PSA, PHI, 4K Score tests was presented. Available test ease qualification for a prostate biopsy or observation. Patients should be qualified individually in deciding on a specific test to be performed. Urologists should be aware of each test mechanism and limitations.
- Open Access
- 12 October 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (11) , 161-170
Penile fracture with urethral rupture - case report
Introduction Penile fracture is a rupture of the tunica albuginea of the corpus cavernosum caused by an erect penis injury. It is noticed that hematomas always accompany penile fractures. We present a rare case of penile fracture between corpus cavernosus and urethra without hematoma formation. Case Presentation: A 41-year-old male patient presented to the emergency department due to a continuous flow of blood from his urethra, which started an hour earlier due to a penile injury during vigorous sexual intercourse. There was no audible 'snap' sound, but the incident was followed by severe pain and immediate loss of tumescence. His bleeding continued until surgery. No hematoma was observed – Figure 1. A urethrography was performed, and afterward, an experienced urologist inserted a catheter without encountering any resistance. The patient was diagnosed with rupturing the tunica albuginea of the corpus cavernosum and the urethra. No hematoma was found, and primary revision was performed. Urethra and tunica albuginea was sutured. After four weeks catheter was removed. The patient recovered with good uroflowmetry results and did not report erectile dysfunction. Conclusions Rapture of tunica albuginea to the urethra may cause severe bleeding without formation of the hematoma and "eggplant deformity." Therefore, early intervention is crucial to sustain erectile function and avoid urethral stricture.
- 12 October 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (11) , 161-170
Open AccessPenile fracture with urethral rupture - case report
Introduction Penile fracture is a rupture of the tunica albuginea of the corpus cavernosum caused by an erect penis injury. It is noticed that hematomas always accompany penile fractures. We present a rare case of penile fracture between corpus cavernosus and urethra without hematoma formation. Case Presentation: A 41-year-old male patient presented to the emergency department due to a continuous flow of blood from his urethra, which started an hour earlier due to a penile injury during vigorous sexual intercourse. There was no audible 'snap' sound, but the incident was followed by severe pain and immediate loss of tumescence. His bleeding continued until surgery. No hematoma was observed – Figure 1. A urethrography was performed, and afterward, an experienced urologist inserted a catheter without encountering any resistance. The patient was diagnosed with rupturing the tunica albuginea of the corpus cavernosum and the urethra. No hematoma was found, and primary revision was performed. Urethra and tunica albuginea was sutured. After four weeks catheter was removed. The patient recovered with good uroflowmetry results and did not report erectile dysfunction. Conclusions Rapture of tunica albuginea to the urethra may cause severe bleeding without formation of the hematoma and "eggplant deformity." Therefore, early intervention is crucial to sustain erectile function and avoid urethral stricture.